Objectives: To evaluate how combining fractional laser-based resurfacing treatments with targeted cosmeceuticals leads to sustained improvement in skin quality, with emphasis on collagen remodeling, texture refinement, and pigment balance.
Introduction: Skin quality has become a central focus of aesthetic dermatology, encompassing tone, texture, firmness, hydration, and clarity. While laser resurfacing offers significant short-term improvements, maintaining and enhancing those results requires long-term skin support. This talk explores how integrating resurfacing procedures with ongoing cosmeceutical use can achieve lasting improvements in skin quality, particularly for aging and pigment-prone skin.
Materials / method: A review of clinical data and expert consensus was conducted, examining studies involving fractional CO₂, Er:YAG, non-ablative lasers, and microneedling RF. This was combined with long-term studies of topical antioxidants, peptides, growth factors, and barrier-repair agents used post-procedure. Studies were selected with a preference for Asian or Fitzpatrick III–V populations.
Results: Fractional laser resurfacing improves texture and dermal collagen for up to 6–12 months.
Adjunctive use of L-ascorbic acid, peptides, and lipids post-resurfacing enhances epidermal integrity and extends visible results.
Longitudinal data support the role of antioxidant and peptide-rich skincare in maintaining radiance, reducing PIH recurrence, and supporting collagen remodeling.
Conclusion: Procedural interventions provide the catalyst for skin quality improvement, but sustained results rely on ongoing skincare. A long-term, phased skincare protocol using clinically validated actives enhances outcomes and prevents regression, especially in pigment-prone skin types. Dermatologists should view resurfacing and cosmeceuticals as partners in long-term aesthetic care.
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.
